ID   HMR1_RAT                Reviewed;         343 AA.
AC   O19477;
DT   22-JUL-2008, integrated into UniProtKB/Swiss-Prot.
DT   22-JUL-2008, sequence version 2.
DT   24-JUL-2024, entry version 136.
DE   RecName: Full=Major histocompatibility complex class I-related gene protein;
DE   AltName: Full=MHC class I-related gene protein;
DE   Flags: Precursor;
GN   Name=Mr1; Synonyms=Hlals;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 25-342, AND TISSUE SPECIFICITY.
RC   STRAIN=Lewis.1W;
RX   PubMed=9553154; DOI=10.1007/s002510050385;
RA   Walter L., Guenther E.;
RT   "Isolation and molecular characterization of the rat MR1 homologue, a non-
RT   MHC-linked class I-related gene.";
RL   Immunogenetics 47:477-482(1998).
CC   -!- FUNCTION: Antigen-presenting molecule specialized in displaying
CC       microbial pyrimidine-based metabolites to alpha-beta T cell receptors
CC       (TCR) on innate-type mucosal-associated invariant T (MAIT) cells. In
CC       complex with B2M preferentially presents riboflavin-derived metabolites
CC       to semi-invariant TCRs on MAIT cells, guiding immune surveillance of
CC       the microbial metabolome at mucosal epithelial barriers (By
CC       similarity). Signature pyrimidine-based microbial antigens are
CC       generated via non-enzymatic condensation of metabolite intermediates of
CC       the riboflavin pathway with by-products arising from other metabolic
CC       pathways such as glycolysis. Typical potent antigenic metabolites are
CC       5-(2-oxoethylideneamino)-6-D-ribitylaminouracil (5-OE-RU) and 5-(2-
CC       oxopropylideneamino)-6-D-ribitylaminouracil (5-OP-RU), products of
CC       condensation of 5-amino-6-D-ribityaminouracil (5-A-RU) with glyoxal or
CC       methylglyoxal by-products, respectively (By similarity). May present
CC       microbial antigens to various MAIT cell subsets, providing for unique
CC       recognition of diverse microbes, including pathogens that do not
CC       synthesize riboflavin. Upon antigen recognition, elicits rapid innate-
CC       type MAIT cell activation to eliminate pathogenic microbes by directly
CC       killing infected cells (By similarity). During T cell development,
CC       drives thymic selection and post-thymic terminal differentiation of
CC       MAIT cells in a process dependent on commensal microflora (By
CC       similarity). Acts as an immune sensor of cancer cell metabolome. May
CC       present a tumor-specific or -associated metabolite essential for cancer
CC       cell survival to a pan-cancer TCR on a non-MAIT CD8-positive T cell
CC       clone, triggering T cell-mediated killing of a wide range of cancer
CC       cell types (By similarity). {ECO:0000250|UniProtKB:Q8HWB0,
CC       ECO:0000250|UniProtKB:Q95460}.
CC   -!- SUBUNIT: Heterotrimer that consists of MR1, B2M and a metabolite
CC       antigen. Forms reversible covalent Schiff base complexes with the
CC       microbial metabolite, which serves as a molecular switch triggering
CC       complete folding, stable association with B2M and translocation of the
CC       ternary complex from endoplasmic reticulum to the plasma membrane. On
CC       antigen-presenting cells, the ternary complex interacts with TCR on
CC       CD8-positive T cells. The molecular machinery involved in antigen
CC       processing remains unknown, but appears to be TAP1-TAP2 and proteasome-
CC       independent. Structurally, MR1-B2M heterodimer adopts a topology
CC       similar to classical MHC class I molecules, with alpha-1 and alpha-2
CC       domains of MR1 forming the antigen-binding cleft composed of two alpha-
CC       helices resting on a floor of 7-stranded anti-parallel beta-pleated
CC       sheet. The ribityl moiety of pyrimidine-based antigens is recognized by
CC       Tyr-95 residue in the CDR3 alpha loop of the invariant TRAV1-2 TCR.
CC       {ECO:0000250|UniProtKB:Q95460}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q95460};
CC       Single-pass type I membrane protein {ECO:0000250|UniProtKB:Q95460}.
CC       Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:Q95460}; Single-
CC       pass type I membrane protein {ECO:0000255}. Golgi apparatus membrane
CC       {ECO:0000250|UniProtKB:Q95460}; Single-pass type I membrane protein
CC       {ECO:0000255}. Early endosome membrane {ECO:0000250|UniProtKB:Q95460};
CC       Single-pass type I membrane protein {ECO:0000255}. Late endosome
CC       membrane {ECO:0000250|UniProtKB:Q95460}; Single-pass type I membrane
CC       protein {ECO:0000255}. Note=In the absence of antigen remains within
CC       the endoplasmic reticulum where it acts as a metabolite sensor. Antigen
CC       binding triggers trafficking of the ternary complex to the plasma
CC       membrane. After presentation, most of these complexes are rapidly
CC       internalized and degraded via endocytosis. A small subset recycles via
CC       endosomes back to the plasma membrane and may thus acquire and present
CC       new antigens that do not efficiently reach the endoplasmic reticulum.
CC       {ECO:0000250|UniProtKB:Q95460}.
CC   -!- TISSUE SPECIFICITY: Expressed in kidney, liver, testis, spleen, thymus,
CC       brain, and heart. {ECO:0000269|PubMed:9553154}.
CC   -!- DOMAIN: The alpha-1 domain is a structural part of antigen-binding
CC       cleft. {ECO:0000250|UniProtKB:Q95460}.
CC   -!- DOMAIN: The alpha-2 domain is a structural part of antigen-binding
CC       cleft. {ECO:0000250|UniProtKB:Q95460}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:Q95460}.
CC   -!- POLYMORPHISM: Does not appear to be polymorphic.
CC   -!- MISCELLANEOUS: MR1 is detected in an open versus folded conformation.
CC       Only the folded MR1 conformer activates MAIT cells (By similarity).
CC       {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR03084784; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Y13972; CAA74305.1; -; mRNA.
DR   RefSeq; NP_001094105.1; NM_001100635.1.
DR   AlphaFoldDB; O19477; -.
DR   SMR; O19477; -.
DR   STRING; 10116.ENSRNOP00000004694; -.
DR   GlyCosmos; O19477; 1 site, No reported glycans.
DR   GlyGen; O19477; 1 site.
DR   PhosphoSitePlus; O19477; -.
DR   PaxDb; 10116-ENSRNOP00000004694; -.
DR   GeneID; 25119; -.
DR   KEGG; rno:25119; -.
DR   UCSC; RGD:1593291; rat.
DR   AGR; RGD:1593291; -.
DR   CTD; 3140; -.
DR   RGD; 1593291; Mr1.
DR   eggNOG; ENOG502RQEK; Eukaryota.
DR   HOGENOM; CLU_047501_0_1_1; -.
DR   InParanoid; O19477; -.
DR   OrthoDB; 3840485at2759; -.
DR   PhylomeDB; O19477; -.
DR   TreeFam; TF336617; -.
DR   PRO; PR:O19477; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0031901; C:early endosome membrane; ISO:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISO:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0031902; C:late endosome membrane; ISO:RGD.
DR   GO; GO:0042612; C:MHC class I protein complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0030881; F:beta-2-microglobulin binding; ISO:RGD.
DR   GO; GO:0042608; F:T cell receptor binding; ISO:RGD.
DR   GO; GO:0019884; P:antigen processing and presentation of exogenous antigen; ISO:RGD.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; IEA:UniProtKB-KW.
DR   GO; GO:0050829; P:defense response to Gram-negative bacterium; ISO:RGD.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; ISO:RGD.
DR   GO; GO:0006955; P:immune response; IBA:GO_Central.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0002854; P:positive regulation of T cell mediated cytotoxicity directed against tumor cell target; ISO:RGD.
DR   GO; GO:0033077; P:T cell differentiation in thymus; ISO:RGD.
DR   CDD; cd07698; IgC1_MHC_I_alpha3; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR   Gene3D; 3.30.500.10; MHC class I-like antigen recognition-like; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR050208; MHC_class-I_related.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR037055; MHC_I-like_Ag-recog_sf.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR001039; MHC_I_a_a1/a2.
DR   PANTHER; PTHR16675:SF272; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-RELATED GENE PROTEIN; 1.
DR   PANTHER; PTHR16675; MHC CLASS I-RELATED; 1.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   PRINTS; PR01638; MHCCLASSI.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 1.
DR   SUPFAM; SSF54452; MHC antigen-recognition domain; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Disulfide bond; Endoplasmic reticulum; Endosome;
KW   Glycoprotein; Golgi apparatus; Immunity; Immunoglobulin domain;
KW   Innate immunity; Membrane; MHC I; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   CHAIN           19..343
FT                   /note="Major histocompatibility complex class I-related
FT                   gene protein"
FT                   /id="PRO_0000344446"
FT   TOPO_DOM        19..298
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        299..319
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        320..343
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          204..286
FT                   /note="Ig-like C1-type"
FT   REGION          19..105
FT                   /note="Alpha-1"
FT                   /evidence="ECO:0000250"
FT   REGION          106..197
FT                   /note="Alpha-2"
FT                   /evidence="ECO:0000250"
FT   REGION          198..289
FT                   /note="Alpha-3"
FT                   /evidence="ECO:0000250"
FT   REGION          290..298
FT                   /note="Connecting peptide"
FT                   /evidence="ECO:0000250"
FT   BINDING         27
FT                   /ligand="5-(2-oxoethylideneamino)-6-(D-ribitylamino)uracil"
FT                   /ligand_id="ChEBI:CHEBI:78397"
FT                   /ligand_note="pathogen-derived metabolite antigen"
FT                   /evidence="ECO:0000250|UniProtKB:Q95460"
FT   BINDING         27
FT                   /ligand="5-(2-oxopropylideneamino)-6-(D-
FT                   ribitylamino)uracil"
FT                   /ligand_id="ChEBI:CHEBI:78398"
FT                   /ligand_note="pathogen-derived metabolite antigen"
FT                   /evidence="ECO:0000250|UniProtKB:Q95460"
FT   BINDING         42
FT                   /ligand="5-(2-oxoethylideneamino)-6-(D-ribitylamino)uracil"
FT                   /ligand_id="ChEBI:CHEBI:78397"
FT                   /ligand_note="pathogen-derived metabolite antigen"
FT                   /evidence="ECO:0000250|UniProtKB:Q95460"
FT   BINDING         42
FT                   /ligand="5-(2-oxopropylideneamino)-6-(D-
FT                   ribitylamino)uracil"
FT                   /ligand_id="ChEBI:CHEBI:78398"
FT                   /ligand_note="pathogen-derived metabolite antigen"
FT                   /evidence="ECO:0000250|UniProtKB:Q95460"
FT   BINDING         61
FT                   /ligand="5-(2-oxoethylideneamino)-6-(D-ribitylamino)uracil"
FT                   /ligand_id="ChEBI:CHEBI:78397"
FT                   /ligand_note="pathogen-derived metabolite antigen"
FT                   /note="covalent"
FT                   /evidence="ECO:0000250|UniProtKB:Q95460"
FT   BINDING         61
FT                   /ligand="5-(2-oxopropylideneamino)-6-(D-
FT                   ribitylamino)uracil"
FT                   /ligand_id="ChEBI:CHEBI:78398"
FT                   /ligand_note="pathogen-derived metabolite antigen"
FT                   /note="covalent"
FT                   /evidence="ECO:0000250|UniProtKB:Q95460"
FT   BINDING         112
FT                   /ligand="5-(2-oxoethylideneamino)-6-(D-ribitylamino)uracil"
FT                   /ligand_id="ChEBI:CHEBI:78397"
FT                   /ligand_note="pathogen-derived metabolite antigen"
FT                   /evidence="ECO:0000250|UniProtKB:Q95460"
FT   BINDING         112
FT                   /ligand="5-(2-oxopropylideneamino)-6-(D-
FT                   ribitylamino)uracil"
FT                   /ligand_id="ChEBI:CHEBI:78398"
FT                   /ligand_note="pathogen-derived metabolite antigen"
FT                   /evidence="ECO:0000250|UniProtKB:Q95460"
FT   BINDING         170
FT                   /ligand="5-(2-oxoethylideneamino)-6-(D-ribitylamino)uracil"
FT                   /ligand_id="ChEBI:CHEBI:78397"
FT                   /ligand_note="pathogen-derived metabolite antigen"
FT                   /evidence="ECO:0000250|UniProtKB:Q95460"
FT   BINDING         170
FT                   /ligand="5-(2-oxopropylideneamino)-6-(D-
FT                   ribitylamino)uracil"
FT                   /ligand_id="ChEBI:CHEBI:78398"
FT                   /ligand_note="pathogen-derived metabolite antigen"
FT                   /evidence="ECO:0000250|UniProtKB:Q95460"
FT   BINDING         171
FT                   /ligand="5-(2-oxoethylideneamino)-6-(D-ribitylamino)uracil"
FT                   /ligand_id="ChEBI:CHEBI:78397"
FT                   /ligand_note="pathogen-derived metabolite antigen"
FT                   /evidence="ECO:0000250|UniProtKB:Q95460"
FT   BINDING         171
FT                   /ligand="5-(2-oxopropylideneamino)-6-(D-
FT                   ribitylamino)uracil"
FT                   /ligand_id="ChEBI:CHEBI:78398"
FT                   /ligand_note="pathogen-derived metabolite antigen"
FT                   /evidence="ECO:0000250|UniProtKB:Q95460"
FT   CARBOHYD        103
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        116..179
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        218..274
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   CONFLICT        284
FT                   /note="V -> I (in Ref. 2; CAA74305)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   343 AA;  39571 MW;  2D1AC536F7E5A626 CRC64;
     MMFLLPFLTV FLAKQSHTRT HSLRYFRLAI SDPGPGVPEF ISVGYVDSHP ITTYDSVTRQ
     KEPRAPWMAE NLAPDHWERY TQLLRGWQRT FQTELRHLQR HYNHSGLHTY QRMIGCELLE
     DGSTTGFLQY AYDGQDFIVF DKDTLSWLAM DNVAHITKRA WEANLHELQY QKNWLEEECI
     AWLKRFLEYG SDALERTEHP VVRTTRKETF PGITTLFCRA HGFYPPEISM IWKKNGEEIV
     QEVDYGGVLP SGDGTYQMWV SVDLDPQTKD IYSCHVEHCG LQMVLEAPQE SGNTLLVANT
     ISGTIILIIV LAGVGALIWR RRSREPKEVM YQPTQVNEGS SPS
//
